BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Leica Biosystems to Advance Artificial Intelligence in Pathology as part of UK Life Sciences Sector Deal

  This agreement draws substantial investment into the sector including the development of a trail-blazing digital pathology program leveraging AI.

  December 21, 2017

   · 

  2 min read
• Drug Development

  Trovagene Announces Activation of Second Clinical Trial Site in Phase Ib/II AML Trial for PCM-075

  This trial is being led by Hematologist Jorge Eduardo Cortes, M.D., Deputy Department Chair, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center.

  December 21, 2017

   · 

  8 min read
• ImmunoMolecular Therapeutics To Present at the 10th Annual Biotech Showcase

  The presentation is scheduled for Tuesday, January 9, 2018 at 10:45 AM PT.

  December 21, 2017

   · 

  3 min read
• Mundipharma Uses Thinfilm’s NFC Solution to Generate Consumer Awareness for New Cold-Prevention Medication

  Beginning in December, Mundipharma will leverage Thinfilm’s complete NFC solution to deploy and manage a consumer-focused mobile marketing campaign promoting its BETADINE Cold Defence nasal spray product.

  December 21, 2017

   · 

  4 min read
• Policy

  NuVasive Comments on Expected Impact of U.S. Tax Reform

  Based on the preliminary assessment of the legislation, the Company believes the new regulations will positively impact its non-GAAP EPS.

  December 21, 2017

   · 

  4 min read
• Acasti Pharma Announces Pricing of US$10 Million Offering of Common Shares and Warrants

  Acasti Pharma announced the pricing of its underwritten offering of 9,900,990 common shares together with accompanying warrants to purchase an aggregate of 8,910,891 common shares at a combined price to the public of US$1.01 per share and accompanying warrant.

  December 21, 2017

   · 

  6 min read
• 

  Business

  Kolon Life Science Faces More Headwinds on Its Gene Therapy As Partner Seeks to Cancel Deal

  Kolon Life Science is facing more headwinds on its gene therapy for degenerative arthritis as a Japanese partner seeks to cancel a license deal signed last year due to negligent reporting on issues related to the late-stage drug candidate.

  December 21, 2017

   · 

  1 min read
• 

  Business

  PENTAX Medical Names Veteran Executive as The Americas Region President and CEO

  PENTAX Medical announced that David Woods, the current Global CMO of PENTAX Medical, has been appointed President of PENTAX Medical of the Americas, effective immediately.

  December 21, 2017

   · 

  2 min read
• 

  Business

  Zomedica, Celsee Ink Deal For Cancer Liquid Biopsy Platform

  Zomedica today announced it has entered into a license and supply agreement with Celsee.

  December 21, 2017

   · 

  8 min read
• Business

  Jacobson Pharma Enters Agreements With Henlius Biotech Inc. to Tap Biologics Market

  Under the licensing Framework Agreement, Jacobson Medical will be granted an exclusive right to develop and market a propriety biosimilar product of Shanghai Henlius in Hong Kong and Macau for a period of 10 years

  December 21, 2017

   · 

  4 min read